Clinical trial
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Champix®…
NCT00483002 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00483002 |
|---|---|
| Title | Post Marketing Surveillance Study To Observe Safety And Efficacy Of Champix® Tablets |
| Official title | Post Marketing Surveillance Study To Observe Safety And Efficacy Of Champix® Tablets |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Smoking Cessation |
| Intervention type | Drug |
| Interventions | varenicline |
| Enrollment | 3,719 |
| Start date | Jun 1, 2007 |
| Primary completion | May 1, 2011 |
| Completion | May 1, 2011 |
| First posted | Jun 6, 2007 |
| Last update posted | May 11, 2012 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: